Status:
COMPLETED
Utility and Acceptability of a Molecular Test in the Management of Sexually Transmitted Diseases in Uganda
Lead Sponsor:
Riccardo Serraino
Collaborating Sponsors:
Societa' Italiana Di Malattie Infettive E Tropicali
Conditions:
Sexually Transmitted Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to assess utility and acceptability of a molecular test in comparison with clinical syndromic approach in the management of sexually transmitted diseases (STD) at ST...
Detailed Description
Sexually transmitted diseases (STDs) are a major cause of long-term disability. Urethral discharge syndrome (UDS), abnormal vaginal discharge (AVD) and genital ulcer disease (GUD) are very common synd...
Eligibility Criteria
Inclusion
- Adult males and females with UDS, AVD and GUD diagnosed as per the current National STD Management Guidelines 201616, who have given informed, written, and signed consent.
Exclusion
- All patients presenting with UDS, AVD and GUD who decline informed and written consent.
- All patients living farther than a 20 km radius from Mulago National Referral Hospital
- All patients presenting with any syndromes not listed above.
- Female patients in their menstrual period.
- Pregnant patients.
- Patients with a previous infection presenting with recurrence or relapse.
Key Trial Info
Start Date :
January 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2025
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT05994495
Start Date
January 15 2024
End Date
March 30 2025
Last Update
April 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mulago National Referral Hospital
Kampala, Uganda, 7051